Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
159 studies found for:    "Gout"
Show Display Options
Rank Status Study
1 Active, not recruiting Lesinurad and Febuxostat Combination Extension Study in Gout
Condition: Gout
Intervention: Drug: lesinurad
2 Completed
Has Results
Lesinurad Monotherapy in Gout Subjects Intolerant to Xanthine Oxidase Inhibitors
Condition: Gout
Interventions: Drug: lesinurad;   Drug: Placebo
3 Withdrawn Allopurinol in Acute Gout
Condition: Gout
Intervention: Drug: allopurinol
4 Completed
Has Results
Open-Label Extension Study for Patients Who Completed a Phase 3 Double-blind Study of PEG-uricase for Symptomatic Gout
Condition: Gout
Intervention: Biological: pegloticase
5 Completed
Has Results
Does Allopurinol Prolong a Treated, Acute Gout Flare?
Condition: Gout
Interventions: Drug: allopurinol;   Drug: Placebo (sugar pill)
6 Completed Study to Evaluate sUA-Lowering Activity, Safety & PK Interaction of Oral BCX4208 & Allopurinol Admin. in Subjects w/Gout
Condition: Gout
Interventions: Drug: Placebo;   Drug: Allopurinol;   Drug: BCX4208
7 Completed
Has Results
Phase 3, Febuxostat, Allopurinol and Placebo-Controlled Study in Gout Subjects.
Condition: Gout
Interventions: Drug: Febuxostat;   Drug: Allopurinol;   Drug: Placebo
8 Completed Italian Observational Study Assessing the Impact of Gout on Patients Disability and Quality of Life
Condition: Gout
Intervention:
9 Completed Assessment of Primary Care Providers' Knowledge and Beliefs Regarding Gout Management
Condition: Gout
Intervention:
10 Completed Study to Evaluate the Urate-Lowering Activity and Safety of Oral BCX4208 Administered in Subjects With Gout
Condition: Gout
Interventions: Drug: placebo;   Drug: BCX4208
11 Terminated
Has Results
Efficacy, Safety And Tolerability Of PF-06743649 In Gout Subjects.
Condition: Gout
Interventions: Drug: PF-06743649;   Other: Placebo
12 Completed A Study of Persons With Gout Who Do Not Respond to or Are Allergic to Conventional Therapy
Condition: Gout
Intervention: Drug: Puricase
13 Completed Long Term Study of Canakinumab (ACZ885) in Patients With Gout
Condition: Gout
Intervention: Drug: Canakinumab
14 Completed
Has Results
Evaluating Efficacy of Canakinumab (ACZ885) in Prevention of Acute Flares in Chronic Gout Patients Initiating Allopurinol Therapy
Condition: Gout
Interventions: Drug: Canakinumab 25 mg;   Drug: Canakinumab 50 mg;   Drug: Canakinumab 100 mg;   Drug: Canakinumab 200 mg;   Drug: Canakinumab 300 mg;   Drug: Canakinumab repeated every 4 week (q4wk);   Drug: Colchicine;   Drug: Allopurinol;   Drug: Placebo Matching Canakinumab;   Drug: Placebo Matching Colchicine
15 Completed
Has Results
Pegylated Recombinant Mammalian Uricase (PEG-uricase) as Treatment for Refractory Gout
Condition: Gout
Intervention: Biological: Pegloticase
16 Completed
Has Results
Safety and Efficacy of Oral Febuxostat in Subjects With Gout
Condition: Gout
Interventions: Drug: Febuxostat;   Drug: Allopurinol
17 Completed Initiation of Allopurinol at First Medical Contact for Acute Attacks of Gout
Conditions: Gout;   Gout Acute
Interventions: Drug: Allopurinol;   Drug: Placebo
18 Active, not recruiting Virtual Gout Clinic
Condition: Gout
Intervention: Behavioral: Pharmacist-Led Intervention
19 Completed Review of Safety Using Rilonacept in Preventing Gout Exacerbations (RE-SURGE)
Condition: Gout
Interventions: Biological: Rilonacept;   Other: Placebo
20 Completed PREventative Study Against URate-Lowering Drug-Induced Gout Exacerbations (PRE-SURGE 2)
Condition: Gout
Interventions: Drug: placebo;   Drug: rilonacept

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.